AMETEK, Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

AMETEK Director Trades $114K In Company Stock

AI-generated analysis

πŸ“‰ AMETEK Director Thomas Amato sold 530 shares of company stock totaling $114,893 in a Form 4 filing on March 25.

πŸ’² The insider transaction occurred while AMETEK shares were down 0.47%, trading at $214.31 per share.

πŸ“Š Over the last three months ending December 31, 2025, AMETEK reported a positive revenue growth rate of 13.44%.

πŸ”’ The company maintains a conservative debt-to-equity ratio of 0.22, which is below industry norms.

🏒 Market capitalization analysis suggests AMETEK holds a robust market position relative to industry standards.

βš–οΈ Gross margin stands at 36.05%, indicating potential concerns regarding cost management compared to peers.

πŸ’° Earnings per share of $1.74 currently lag behind the industry average, signaling profitability challenges.

πŸ“ˆ The stock's Price-to-Earnings ratio of 33.65 is noted as below industry norms, suggesting potential undervaluation.

πŸ’΅ A high Price-to-Sales ratio of 6.73 may indicate the stock is overvalued based on sales performance metrics.

🏭 AMETEK operates across two main groups: electronic instruments and electromechanical segments serving niche markets.

πŸ“œ Insider selling does not necessarily signal a bearish view, as executives may sell for various personal reasons.

πŸ“… Form 4 filings must be completed within two business days of the transaction to comply with SEC regulations.

πŸ”Ž The enterprise value-to-EBITDA ratio of 22.24 suggests a potential value opportunity for investors paying less per unit of EBITDA.

Bullish Signals
  • AMETEK achieved a noteworthy revenue growth rate of 13.44% as of December 31, 2025, demonstrating strong top-line earnings expansion.
  • The company maintains a healthy debt-to-equity ratio of 0.22, which is significantly below industry norms and indicates robust debt management.
  • With a current P/E ratio of 33.65, AMETEK is trading below industry averages, suggesting potential undervaluation and presenting an attractive investment opportunity.
  • AMETEK holds a lower-than-industry-average EV/EBITDA ratio of 22.24, indicating that investors are paying less for each unit of earnings before interest, taxes, depreciation, and amortization compared to peers.
  • The company owns over 40 autonomous industrial businesses operating across high-growth sectors such as aerospace, energy, medical, and research, positioning it well in niche markets.
  • Management's insider sell of $114K was explicitly noted as not necessarily indicating a bearish view, allowing investors to focus on the positive financial fundamentals despite the transaction.
Risk Factors
  • Director Thomas Amato executed a significant insider sale of 530 shares, valued at $114,893, potentially signaling reduced confidence in near-term stock performance.
  • The stock is down by 0.47% and trading at $214.31, indicating recent bearish sentiment despite the news coverage.
  • Gross margin stands at a low 36.05%, raising concerns about cost management and overall profitability relative to industry counterparts.
  • AMETEK's EPS of 1.74 lags behind the industry average, suggesting weaker earnings power compared to peers in the Industrials sector.
  • The Price to Sales ratio is relatively high at 6.73 compared to industry norms, indicating potential overvaluation based on sales performance.
  • Revenue growth rate of 13.44% as of December 31, 2025, is lower than the average among peers in the Industrials sector, highlighting competitive challenges.
Full Analysis
AMETEK Director Thomas Amato executed a significant insider transaction on March 25, selling 530 shares of company stock with a total value of $114,893, according to an SEC Form 4 filing disclosed on Wednesday. At the time of reporting Thursday morning, AMETEK shares were trading at $214.31, having dropped by 0.47%. While insider sales do not automatically signal a bearish outlook as they can be motivated by various factors such as diversification or pre-planned programs, this transaction is noted as a notable insider sell against a backdrop of mixed financial performance indicators. Financially, AMETEK has demonstrated positive momentum with a 13.44% revenue growth rate as of December 31, 2025, though this top-line growth lags behind the average for its Industrials sector peers. The company maintains a conservative balance sheet with a debt-to-equity ratio of 0.22, which is below industry norms, and holds substantial market capitalization indicating robust size and dominance. However, profitability metrics present mixed signals; the company reports a low gross margin of 36.05% and EPS of $1.74 that trails industry averages, raising concerns about cost management and relative profitability compared to competitors. Valuation multiples for AMETEK suggest conflicting investment opportunities depending on the metric used. The stock trades at a P/E ratio of 33.65, which is below industry norms, while its Price-to-Sales ratio sits at 6.73, appearing relatively high and suggesting potential overvaluation based on sales performance. Conversely, the EV/EBITDA ratio of 22.24 is lower than the industry average, implying the enterprise value may be undervalued relative to earnings before interest, taxes, depreciation, and amortization. The company operates through two primary segments: the electronic instruments group (EIG) and the electromechanical group (EMG), specializing in niche markets across research, aerospace, energy, medical, and manufacturing sectors with a focus on product differentiation.